- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1083
Companies which are more than 50% undervalued based on analyst price target.
1083 companies
JBS
Market Cap: US$14.6b
Operates as a protein and food company worldwide.
JBS
US$13.44
7D
-0.2%
1Y
n/a
Centene
Market Cap: US$13.9b
Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.
CNC
US$29.42
7D
-3.3%
1Y
-55.5%
BioMarin Pharmaceutical
Market Cap: US$11.4b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$59.67
7D
2.2%
1Y
-29.5%
Aurora Innovation
Market Cap: US$10.9b
Operates as a self-driving technology company in the United States.
AUR
US$6.47
7D
6.8%
1Y
56.3%
Molina Healthcare
Market Cap: US$9.8b
Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
MOH
US$190.25
7D
-11.9%
1Y
-34.1%
VinFast Auto
Market Cap: US$8.4b
Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.
VFS
US$3.66
7D
3.4%
1Y
-9.9%
Legend Biotech
Market Cap: US$8.2b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$44.32
7D
11.5%
1Y
-25.7%
Corcept Therapeutics
Market Cap: US$7.3b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$68.39
7D
-6.1%
1Y
98.3%
Globus Medical
Market Cap: US$7.2b
A medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
GMED
US$54.04
7D
-4.5%
1Y
-25.6%
Revolution Medicines
Market Cap: US$7.1b
A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
RVMD
US$37.53
7D
-2.3%
1Y
-19.3%
Jazz Pharmaceuticals
Market Cap: US$7.0b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$117.34
7D
1.1%
1Y
7.9%
Repligen
Market Cap: US$6.4b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$117.13
7D
-2.2%
1Y
-10.9%
Axsome Therapeutics
Market Cap: US$5.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$106.36
7D
-4.5%
1Y
24.8%
Lantheus Holdings
Market Cap: US$5.0b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$73.31
7D
-1.5%
1Y
-35.5%
Chagee Holdings
Market Cap: US$4.6b
Through its subsidiaries, owns, operates, and franchises teahouses under the CHAGEE brand name in the People’s Republic of China and internationally.
CHA
US$25.63
7D
-2.7%
1Y
n/a
Vaxcyte
Market Cap: US$4.6b
A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
PCVX
US$36.46
7D
-0.3%
1Y
-57.2%
Cytokinetics
Market Cap: US$4.5b
A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.
CYTK
US$37.93
7D
-1.9%
1Y
-33.2%
Alkermes
Market Cap: US$4.5b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$27.19
7D
-6.9%
1Y
2.6%
Zai Lab
Market Cap: US$4.1b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB
US$37.37
7D
5.4%
1Y
95.9%
ADMA Biologics
Market Cap: US$4.1b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$17.20
7D
-2.8%
1Y
26.7%
Avidity Biosciences
Market Cap: US$4.0b
A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).
RNA
US$33.92
7D
1.2%
1Y
-24.0%
Arcellx
Market Cap: US$3.9b
Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.
ACLX
US$69.97
7D
-1.0%
1Y
12.7%
Inspire Medical Systems
Market Cap: US$3.8b
A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
INSP
US$131.55
7D
3.2%
1Y
-5.8%
Viking Therapeutics
Market Cap: US$3.8b
A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
VKTX
US$33.40
7D
5.6%
1Y
-33.7%
Zeta Global Holdings
Market Cap: US$3.7b
Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.
ZETA
US$16.56
7D
10.6%
1Y
-15.9%
CleanSpark
Market Cap: US$3.6b
Operates as a bitcoin mining company in the Americas.
CLSK
US$12.45
7D
-1.0%
1Y
-24.9%
Remitly Global
Market Cap: US$3.5b
Engages in the provision of digital financial services in the United States, Canada, and internationally.
RELY
US$17.41
7D
-0.2%
1Y
31.1%
Intapp
Market Cap: US$3.4b
Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.
INTA
US$42.50
7D
-2.1%
1Y
18.3%
Cellebrite DI
Market Cap: US$3.4b
Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
CLBT
US$14.71
7D
3.5%
1Y
10.9%
GEO Group
Market Cap: US$3.3b
Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.
GEO
US$23.67
7D
-7.2%
1Y
51.6%
Globalstar
Market Cap: US$3.3b
Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.
GSAT
US$26.10
7D
-5.0%
1Y
46.2%
Enovix
Market Cap: US$3.3b
Designs, develops, and manufactures lithium-ion battery cells in the United States and internationally.
ENVX
US$14.56
7D
-3.6%
1Y
-3.7%
WW International
Market Cap: US$3.2b
Provides weight management products and services in the United States, Germany, and internationally.
WW
US$38.83
7D
11.3%
1Y
n/a
Immunovant
Market Cap: US$3.1b
A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.
IMVT
US$18.39
7D
3.3%
1Y
-34.2%
Braze
Market Cap: US$3.1b
Operates a customer engagement platform that provides interactions between consumers and brands worldwide.
BRZE
US$28.45
7D
4.5%
1Y
-26.1%
Alight
Market Cap: US$2.9b
A technology-enabled services company worldwide.
ALIT
US$5.72
7D
2.7%
1Y
-22.1%